Study of imatinib monotherapy and combination of imatinib with IFN or cytarabine ocfosfate for chronic-phase CML (JALSG CML202 Study).
Phase of Trial: Phase II
Latest Information Update: 12 May 2016
At a glance
- Drugs Imatinib (Primary) ; Cytarabine ocfosfate; Interferon
- Indications Chronic myeloid leukaemia
- Focus Therapeutic Use
- 12 May 2016 Status changed from active, no longer recruiting to completed.
- 08 Jun 2009 New trial record.